NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.170
-0.030 (-2.50%)
Dec 5, 2025, 4:00 PM EST - Market closed
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $29.30 million as of December 5, 2025. Its market cap has increased by 28.59% in one year.
Market Cap
29.30M
Enterprise Value
28.63M
1-Year Change
28.59%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $29.30M, a decrease of -54.65%. That is a compound annual growth rate of -17.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.30M | 5.58% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.51B |
| Johnson & Johnson | 496.24B |
| AbbVie | 407.47B |
| UnitedHealth Group | 308.47B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 255.40B |
| Thermo Fisher Scientific | 218.43B |